Weighing the benefits of a deeper quantitative review for pharma.
Frank S. David, MD PhD
Advertisement
Articles by Frank S. David, MD PhD
How drug developers can include strategy in R&D portfolio review to decide how to allocate resources across current and future projects.
Advertisement
Latest Updated Articles
A Strategic Approach to Pharma R&D Portfolio PlanningPublished: April 23rd 2019 | Updated:
A Strategic Approach to Pharma R&D Portfolio PlanningPublished: May 1st 2019 | Updated:
